Procter & Gamble Valuation
Is PG * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PG * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PG * (MX$2765.01) is trading above our estimate of fair value (MX$2628.54)
Significantly Below Fair Value: PG * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PG *?
Other financial metrics that can be useful for relative valuation.
What is PG *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$385.65b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.9x |
Enterprise Value/EBITDA | 17x |
PEG Ratio | 3.6x |
Price to Earnings Ratio vs Peers
How does PG *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 22.1x | ||
KIMBER A Kimberly-Clark de México S. A. B. de C. V | 15x | 6.8% | Mex$108.9b |
CL Colgate-Palmolive | 29.2x | 7.7% | US$75.4b |
KMB Kimberly-Clark | 24.9x | 9.4% | US$46.0b |
RKT Reckitt Benckiser Group | 19.3x | 11.0% | UK£31.5b |
PG * Procter & Gamble | 26x | 7.2% | Mex$385.6b |
Price-To-Earnings vs Peers: PG * is expensive based on its Price-To-Earnings Ratio (26x) compared to the peer average (22x).
Price to Earnings Ratio vs Industry
How does PG *'s PE Ratio compare vs other companies in the Global Household Products Industry?
Price-To-Earnings vs Industry: PG * is expensive based on its Price-To-Earnings Ratio (26x) compared to the Global Household Products industry average (18.2x).
Price to Earnings Ratio vs Fair Ratio
What is PG *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PG *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,765.01 | Mex$2,880.26 +4.2% | 5.4% | Mex$3,098.94 | Mex$2,421.58 | n/a | 22 |
Apr ’25 | Mex$2,673.53 | Mex$2,817.19 +5.4% | 5.2% | Mex$2,998.62 | Mex$2,348.92 | n/a | 25 |
Mar ’25 | Mex$2,670.01 | Mex$2,875.18 +7.7% | 5.6% | Mex$3,076.94 | Mex$2,358.99 | n/a | 24 |
Feb ’25 | Mex$2,712.25 | Mex$2,869.67 +5.8% | 5.7% | Mex$3,054.25 | Mex$2,367.90 | n/a | 24 |
Jan ’25 | Mex$2,483.00 | Mex$2,821.54 +13.6% | 6.7% | Mex$3,038.72 | Mex$2,369.17 | n/a | 24 |
Dec ’24 | Mex$2,620.00 | Mex$2,844.77 +8.6% | 6.8% | Mex$3,064.51 | Mex$2,389.28 | n/a | 24 |
Nov ’24 | Mex$2,669.68 | Mex$2,971.33 +11.3% | 6.8% | Mex$3,215.05 | Mex$2,470.32 | n/a | 23 |
Oct ’24 | Mex$2,528.52 | Mex$2,931.00 +15.9% | 6.3% | Mex$3,138.17 | Mex$2,384.31 | n/a | 23 |
Sep ’24 | Mex$2,605.00 | Mex$2,794.48 +7.3% | 6.4% | Mex$3,000.02 | Mex$2,279.35 | n/a | 22 |
Aug ’24 | Mex$2,610.00 | Mex$2,787.78 +6.8% | 7.3% | Mex$2,997.25 | Mex$2,160.03 | n/a | 21 |
Jul ’24 | Mex$2,556.00 | Mex$2,812.82 +10.0% | 7.2% | Mex$3,028.82 | Mex$2,207.45 | n/a | 22 |
Jun ’24 | Mex$2,575.49 | Mex$2,932.18 +13.8% | 7.2% | Mex$3,195.13 | Mex$2,289.84 | n/a | 23 |
May ’24 | Mex$2,817.09 | Mex$2,963.47 +5.2% | 7.8% | Mex$3,257.55 | Mex$2,280.29 | Mex$2,765.01 | 24 |
Apr ’24 | Mex$2,676.83 | Mex$2,904.56 +8.5% | 7.3% | Mex$3,199.94 | Mex$2,371.72 | Mex$2,673.53 | 26 |
Mar ’24 | Mex$2,488.02 | Mex$2,794.11 +12.3% | 7.4% | Mex$3,077.49 | Mex$2,280.97 | Mex$2,670.01 | 26 |
Feb ’24 | Mex$2,656.01 | Mex$2,890.46 +8.8% | 7.3% | Mex$3,190.76 | Mex$2,364.92 | Mex$2,712.25 | 26 |
Jan ’24 | Mex$2,958.00 | Mex$2,949.37 -0.3% | 9.0% | Mex$3,360.71 | Mex$2,411.81 | Mex$2,483.00 | 26 |
Dec ’23 | Mex$2,860.00 | Mex$2,864.50 +0.2% | 8.6% | Mex$3,301.01 | Mex$2,368.96 | Mex$2,620.00 | 25 |
Nov ’23 | Mex$2,604.03 | Mex$2,918.31 +12.1% | 7.7% | Mex$3,390.29 | Mex$2,433.03 | Mex$2,669.68 | 24 |
Oct ’23 | Mex$2,632.11 | Mex$3,105.30 +18.0% | 8.1% | Mex$3,596.35 | Mex$2,497.46 | Mex$2,528.52 | 22 |
Sep ’23 | Mex$2,812.78 | Mex$3,119.83 +10.9% | 8.1% | Mex$3,600.54 | Mex$2,500.38 | Mex$2,605.00 | 22 |
Aug ’23 | Mex$2,900.00 | Mex$3,184.81 +9.8% | 8.0% | Mex$3,667.30 | Mex$2,526.36 | Mex$2,610.00 | 22 |
Jul ’23 | Mex$2,957.03 | Mex$3,303.73 +11.7% | 8.3% | Mex$3,719.87 | Mex$2,493.32 | Mex$2,556.00 | 23 |
Jun ’23 | Mex$2,861.29 | Mex$3,272.57 +14.4% | 8.4% | Mex$3,645.15 | Mex$2,443.23 | Mex$2,575.49 | 22 |
May ’23 | Mex$3,290.10 | Mex$3,394.18 +3.2% | 8.1% | Mex$3,736.48 | Mex$2,504.45 | Mex$2,817.09 | 23 |
Analyst Forecast: Target price is less than 20% higher than the current share price.